Barely Significant
← all phrases

“nominally significant”

7,733 sentences · 7,733 papers · 10,034 search hits before verification · confirmed specimen

Sighted at

p=0.08

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

nominally significantP = 0.04200.8× alphagold
There was a nominally significant benefit for GAD-alum treatment compared with placebo in lowering the increase in the standard deviation of blood glucose readings during the study period ( P = 0.0420 at 6 months, and P = 0.0219 at 15 months; Suppl Fig 1 ( 24 )), but there was no significant difference between the treatment arms regarding the coefficient of variation (standard deviation divided by the mean) measure of glycemic variability (Suppl Fig 2 ( 24 )).
nominally significantP = 0.0420.8× alphagold
In our supplemental analysis ( n = 33; Table S2 ), we observed a nominally significant reduction in SL (from 1.6 to 0.8 min, P = 0.042), a non‐significant yet clinically meaningful decrease in and the decrease TIB (from 527.5 to 479.0 min, P = 0.201), and no change in TST from 418.0 to 415.7 min, P = 0.416).
nominally significantp = 0.0420.8× alphagold
In addition, we found nominally significant or suggestive associations of rs1237999 (A allele) with lower levels of CSF Aβ42 (p = 0.042) as well as higher levels of tau (p = 0.030), ptau (p = 0.011), and the ptau/Aβ42 ratio (p = 0.045) in the non-demented population ( Figure 2A ).
nominally significantp = 4.20 × 10 −20.8× alphagold
Replication results In 461 adolescents, GMV IC 1-SNP component association was nominally significant after controlling for medication and five genomic ancestry components (uncorrected p = 4.20 × 10 −2 , \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\eta _p^2$$\end{document} η p 2 = 0.17).
nominally significantP = 0.0430.9× alphagold
cruzi infection susceptibility The allelic and genotypic frequencies of seronegative and seropositive individuals from the Colombian cohort were compared in Tables S3–1 The minor allele frequency (MAF), in rs8193036*C was higher in seronegative than in seropositive individuals, being nominally significant after the adjustment by sex and age [P = 0.043, odds ratio (OR) = 0.83, 95% confidence interval (CI) = 0.70–0.99].
nominally significantP = 0.0430.9× alphagold
However, in post hoc analyses, it was observed that among subjects with high baseline TG levels [≥1.69 mmol/L (150 mg/dL)] and low HDL-C levels [<1.03 mmol/L (40 mg/dL)] who exhibited the highest risk of coronary events, there was a nominally significant 53% reduction in events [HR 0.47, 95% confidence interval (CI) 0.23–0.98; P = 0.043]. 38 Of note, the benefits seen in JELIS were consistent in both the secondary and primary prevention cohorts enrolled.
nominally significantP = 0.0430.9× alphagold
Comparison of aFTLD-U cases with and without chr15q14 risk haplotypes We observed a nominally significant difference in age at death ( P = 0.043; Fig. 7a ) between aFTLD-U cases carrying haplotype A or B and those without association to chr15q14, with a subset of those without the haplotype showing an earlier age at death.
nominally significantp = 0.0430.9× alphagold
Among the variants that were included on the exome array, there was one nominally significant association with A-kinase anchoring protein 9 ( AKAP9 ) rs149979685 ( β = −3.117 (SE = 1.538) number–symbol pairs; p = 0.043) in African-Americans after adjusting for age and gender that did not survive adjustment for multiple comparisons (Supplementary Tables 6 , 7 ).